Cargando…

Cathepsin-L and transglutaminase dependent processing of ps20: A novel mechanism for ps20 regulation via ECM cross-linking

Whey-acidic-protein (WAP) four-disulphide core (WFDC) proteins have important roles in the regulation of innate immunity, anti-microbial function, and the inhibition of inflammatory proteases at mucosal surfaces. It was recently demonstrated that the WFDC protein, prostate stromal 20 (ps20), encoded...

Descripción completa

Detalles Bibliográficos
Autores principales: Hickman, Oliver J., Dasgupta, Prokar, Galustian, Christine, Smith, Richard A., Vyakarnam, Annapurna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5613349/
https://www.ncbi.nlm.nih.gov/pubmed/28955923
http://dx.doi.org/10.1016/j.bbrep.2016.06.010
_version_ 1783266235533754368
author Hickman, Oliver J.
Dasgupta, Prokar
Galustian, Christine
Smith, Richard A.
Vyakarnam, Annapurna
author_facet Hickman, Oliver J.
Dasgupta, Prokar
Galustian, Christine
Smith, Richard A.
Vyakarnam, Annapurna
author_sort Hickman, Oliver J.
collection PubMed
description Whey-acidic-protein (WAP) four-disulphide core (WFDC) proteins have important roles in the regulation of innate immunity, anti-microbial function, and the inhibition of inflammatory proteases at mucosal surfaces. It was recently demonstrated that the WFDC protein, prostate stromal 20 (ps20), encoded by the WFDC1 gene, is a potent growth inhibitory factor, and shares with other WFDC proteins the ability to modulate wound healing processes and immune responses to viral infections. However, ps20 remains relatively uncharacterised at the protein level. Using a panel of ps20 antibodies for western-blotting (WB), ELISA and immunoaffinity purification, we isolated, biochemically characterised and tested ps20 preparations for three biological properties: (i) interactions with glycosaminoglycans (GAG) (ii) inhibition of cell proliferation, and (iii) transglutaminase2 (TG2) mediated crosslinking of ps20 to fibronectin, a process implicated in wound healing. We show herein that ps20 preparations contain multiple molecular forms including full-length ps20 (resolving at ≈27 kDa), an exon 3 truncated form (≈22 kDa) that lacks aa113–140, and variable amounts of a putatively cleaved lower MW (≈15–17 kDa) species. Untagged purified ps20 preparations containing a mixture of these forms are biologically active in significantly suppressing prostate cell proliferation. We show that one mechanism by which lower LMW forms of ps20 arise is through cathepsin L (CL) cleavage, and confirm that CL cleaves ps20 at the C-terminus, but this does not inhibit its growth inhibitory function. However, CL cleavage abrogated the interaction between ps20 and solid-phase fibronectin. Therefore, we demonstrate for the first time that LMW forms of ps20 that lack a C-terminal immunogenic epitope can arise through CL cleavage and this cleavage impairs multimerisation and potential capacity to cross-link to ECM, but not the capacity of ps20 to inhibit cell proliferation. We propose that ps20 like other WFDC proteins can become associated with GAGs and the ECM. Furthermore, we suggest post-translational processing and cleavage of ps20 is required to generate functional protein species, and TG2 mediated crosslinking and CL cleavage form components of a ps20 regulatory apparatus.
format Online
Article
Text
id pubmed-5613349
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-56133492017-09-27 Cathepsin-L and transglutaminase dependent processing of ps20: A novel mechanism for ps20 regulation via ECM cross-linking Hickman, Oliver J. Dasgupta, Prokar Galustian, Christine Smith, Richard A. Vyakarnam, Annapurna Biochem Biophys Rep Research Article Whey-acidic-protein (WAP) four-disulphide core (WFDC) proteins have important roles in the regulation of innate immunity, anti-microbial function, and the inhibition of inflammatory proteases at mucosal surfaces. It was recently demonstrated that the WFDC protein, prostate stromal 20 (ps20), encoded by the WFDC1 gene, is a potent growth inhibitory factor, and shares with other WFDC proteins the ability to modulate wound healing processes and immune responses to viral infections. However, ps20 remains relatively uncharacterised at the protein level. Using a panel of ps20 antibodies for western-blotting (WB), ELISA and immunoaffinity purification, we isolated, biochemically characterised and tested ps20 preparations for three biological properties: (i) interactions with glycosaminoglycans (GAG) (ii) inhibition of cell proliferation, and (iii) transglutaminase2 (TG2) mediated crosslinking of ps20 to fibronectin, a process implicated in wound healing. We show herein that ps20 preparations contain multiple molecular forms including full-length ps20 (resolving at ≈27 kDa), an exon 3 truncated form (≈22 kDa) that lacks aa113–140, and variable amounts of a putatively cleaved lower MW (≈15–17 kDa) species. Untagged purified ps20 preparations containing a mixture of these forms are biologically active in significantly suppressing prostate cell proliferation. We show that one mechanism by which lower LMW forms of ps20 arise is through cathepsin L (CL) cleavage, and confirm that CL cleaves ps20 at the C-terminus, but this does not inhibit its growth inhibitory function. However, CL cleavage abrogated the interaction between ps20 and solid-phase fibronectin. Therefore, we demonstrate for the first time that LMW forms of ps20 that lack a C-terminal immunogenic epitope can arise through CL cleavage and this cleavage impairs multimerisation and potential capacity to cross-link to ECM, but not the capacity of ps20 to inhibit cell proliferation. We propose that ps20 like other WFDC proteins can become associated with GAGs and the ECM. Furthermore, we suggest post-translational processing and cleavage of ps20 is required to generate functional protein species, and TG2 mediated crosslinking and CL cleavage form components of a ps20 regulatory apparatus. Elsevier 2016-06-15 /pmc/articles/PMC5613349/ /pubmed/28955923 http://dx.doi.org/10.1016/j.bbrep.2016.06.010 Text en © 2016 Published by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Hickman, Oliver J.
Dasgupta, Prokar
Galustian, Christine
Smith, Richard A.
Vyakarnam, Annapurna
Cathepsin-L and transglutaminase dependent processing of ps20: A novel mechanism for ps20 regulation via ECM cross-linking
title Cathepsin-L and transglutaminase dependent processing of ps20: A novel mechanism for ps20 regulation via ECM cross-linking
title_full Cathepsin-L and transglutaminase dependent processing of ps20: A novel mechanism for ps20 regulation via ECM cross-linking
title_fullStr Cathepsin-L and transglutaminase dependent processing of ps20: A novel mechanism for ps20 regulation via ECM cross-linking
title_full_unstemmed Cathepsin-L and transglutaminase dependent processing of ps20: A novel mechanism for ps20 regulation via ECM cross-linking
title_short Cathepsin-L and transglutaminase dependent processing of ps20: A novel mechanism for ps20 regulation via ECM cross-linking
title_sort cathepsin-l and transglutaminase dependent processing of ps20: a novel mechanism for ps20 regulation via ecm cross-linking
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5613349/
https://www.ncbi.nlm.nih.gov/pubmed/28955923
http://dx.doi.org/10.1016/j.bbrep.2016.06.010
work_keys_str_mv AT hickmanoliverj cathepsinlandtransglutaminasedependentprocessingofps20anovelmechanismforps20regulationviaecmcrosslinking
AT dasguptaprokar cathepsinlandtransglutaminasedependentprocessingofps20anovelmechanismforps20regulationviaecmcrosslinking
AT galustianchristine cathepsinlandtransglutaminasedependentprocessingofps20anovelmechanismforps20regulationviaecmcrosslinking
AT smithricharda cathepsinlandtransglutaminasedependentprocessingofps20anovelmechanismforps20regulationviaecmcrosslinking
AT vyakarnamannapurna cathepsinlandtransglutaminasedependentprocessingofps20anovelmechanismforps20regulationviaecmcrosslinking